Fibroblast Growth Factor Receptor 2 Isoforms Detected via Novel RNA ISH as Predictive Biomarkers for Progestin Therapy in Atypical Hyperplasia and Low-Grade Endometrial Cancer by Asmerom T. Sengal, Deborah Smith, Rebecca Rogers, Cameron E. Snell, Elizabeth D. Williams, Pamela M. Pollock

Get full text

Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series by Asmerom Tesfamariam Sengal, Nada Suliman Haj-Mukhtar, Ahmed Mohammed Elhaj, Shahinaz Bedri, Eva Johanna Kantelhardt, Ahmed A. Mohamedani

Get full text

Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma by Asmerom T Sengal, Deborah Smith, Cameron E Snell, Samuel Leung, Aline Talhouk, Elizabeth D Williams, Jessica N McAlpine, Pamela M Pollock

Get full text

Comparison of Receptor-Defined Breast Cancer Subtypes Between German and Sudanese Women: A Facility-Based Cohort Study by Asmerom Tesfamariam Sengal, Nada Suliman Haj Mukhtar, Martina Vetter, Ahmed Mohammed Elhaj, Shahinaz Bedri, Steffen Hauptmann, Christoph Thomssen, Ahmed Abdalla Mohamedani, Claudia Wickenhauser, Eva Johanna Kantelhardt

Get full text

Endometrial cancer PDX-derived organoids (PDXOs) and PDXs with FGFR2c isoform expression are sensitive to FGFR inhibition by Asmerom T. Sengal, Vanessa Bonazzi, Deborah Smith, Cristian P. Moiola, Rohan Lourie, Rebecca Rogers, Eva Colas, Antonio Gil-Moreno, Sophia Frentzas, Naven Chetty, Lewis Perrin, Pamela M. Pollock

Get full text

Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer by Vanessa F. Bonazzi, Olga Kondrashova, Deborah Smith, Katia Nones, Asmerom T. Sengal, Robert Ju, Leisl M. Packer, Lambros T. Koufariotis, Stephen H. Kazakoff, Aimee L. Davidson, Priya Ramarao-Milne, Vanessa Lakis, Felicity Newell, Rebecca Rogers, Claire Davies, James Nicklin, Andrea Garrett, Naven Chetty, Lewis Perrin, John V. Pearson, Ann-Marie Patch, Nicola Waddell, Pamela M. Pollock

Get full text